Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common side effect of hormone treatments for cancer.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Minoxidil can reduce functions related to androgen receptors.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

People undergoing chemotherapy need better support and information to cope with hair loss.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Finasteride treats hair loss but may affect prostate cancer detection.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.